Ranked #3,619 of 8,699 institutional investors
Seven Fleet Capital Management LP
Mountain View, CA
$501M
US stock portfolio at live prices · today −$4.7M (−0.93%)
Live prices, last trade 11:35 AM ET
- Value at quarter end (Q3 2026)
- $512M
- Change from Q2 2026
- −$94.2M (−15.54%)
- Positions
- 75 · 15 new, 27 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$64.9M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesCGON 30.8%TNGX 9.96%RVMD 8.63%LQDA 6.59%XNCR 2.98%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| CGON CG Oncology, Inc. | 1,886,236 | $154M | 30.8% | Unchanged |
| TNGX Tango Therapeutics, Inc. | 2,232,864 | $49.9M | 9.96% | Reduced −31% |
| RVMD Revolution Medicines, Inc. | 264,588 | $43.2M | 8.63% | Added +9% |
| LQDA Liquidia Corporation | 596,275 | $33.0M | 6.59% | Added +132% |
| XNCR Xencor, Inc. | 444,937 | $14.9M | 2.98% | Added +21% |
| ELVN Enliven Therapeutics, Inc. | 261,957 | $12.2M | 2.43% | Reduced −28% |
| MANE Veradermics Inc | 80,000 | $9.7M | 1.94% | Unchanged |
| ASMB Assembly Biosciences, Inc. | 417,441 | $9.3M | 1.85% | Reduced −4% |
| SLN Silence Therapeutics plc | 350,000 | $6.9M | 1.38% | Added +482% |
| ABVX ABIVAX Société Anonyme | 99,274 | $6.9M | 1.38% | Reduced −11% |
| PTGX Protagonist Therapeutics, Inc. | 45,659 | $5.6M | 1.12% | Added +1% |
| IPSC Century Therapeutics, Inc. | 4,421,739 | $5.4M | 1.08% | Added +2% |
| AVTX Avalo Therapeutics, Inc. | 772,660 | $5.2M | 1.04% | Added +0% |
| IMUX Immunic, Inc. | 687,240 | $5.0M | 0.99% | New |
| AVBP ArriVent BioPharma, Inc. | 451,173 | $5.0M | 0.99% | Added +83% |
| DNTH Dianthus Therapeutics, Inc. | 46,432 | $3.9M | 0.78% | Reduced −28% |
| SGMT Sagimet Biosciences Inc. | 429,113 | $3.9M | 0.78% | Added +6% |
| TARS Tarsus Pharmaceuticals, Inc. | 48,530 | $3.6M | 0.72% | Reduced −59% |
| EPRX Eupraxia Pharmaceuticals Inc. | 572,267 | $3.4M | 0.68% | Reduced −6% |
| EDIT Editas Medicine, Inc. | 1,915,871 | $3.3M | 0.66% | Added +44% |
| PRAX Praxis Precision Medicines, Inc. | 10,489 | $3.2M | 0.64% | Added +39% |
| DFTX Definium Therapeutics, Inc. | 108,647 | $3.2M | 0.63% | Reduced −27% |
| AXSM Axsome Therapeutics, Inc. | 24,066 | $3.1M | 0.63% | Reduced −17% |
| RLAY Relay Therapeutics, Inc. | 185,733 | $3.0M | 0.60% | Added +4% |
| TSHA Taysha Gene Therapies, Inc. | 750,000 | $2.8M | 0.56% | Reduced −50% |
| CYTK Cytokinetics, Incorporated | 53,748 | $2.8M | 0.56% | Reduced −55% |
| ZLAB Zai Lab Limited | 118,395 | $2.5M | 0.49% | Reduced −13% |
| CTMX CytomX Therapeutics, Inc. | 1,085,398 | $2.2M | 0.45% | Unchanged |
| ZNTL Zentalis Pharmaceuticals, Inc. | 1,504,231 | $2.2M | 0.44% | Added +374% |
| SABS SAB Biotherapeutics, Inc. | 752,772 | $2.1M | 0.42% | Added +2% |
| NERV Minerva Neurosciences, Inc. | 1,001,373 | $2.1M | 0.41% | Unchanged |
| UTHR United Therapeutics Corporation | 2,940 | $1.6M | 0.33% | New |
| IVA Inventiva S.A. | 414,341 | $1.4M | 0.27% | Added +107% |
| ANTX AN2 Therapeutics, Inc. | 254,309 | $1.3M | 0.26% | Added +22% |
| PCVX Vaxcyte, Inc. | 22,066 | $1.3M | 0.25% | Reduced −26% |
| HRMY Harmony Biosciences Holdings, Inc. | 37,900 | $1.3M | 0.25% | New |
| CLDX Celldex Therapeutics, Inc. | 40,868 | $1.1M | 0.22% | Reduced −53% |
| SYRE Spyre Therapeutics, Inc. | 11,611 | $1.1M | 0.22% | Reduced −13% |
| ANL Adlai Nortye Group Ltd. | 116,185 | $1.0M | 0.20% | Added +3% |
| STRO Sutro Biopharma, Inc. | 99,894 | $884K | 0.18% | Reduced −37% |
| CRVS Corvus Pharmaceuticals, Inc. | 84,590 | $821K | 0.16% | Added +2% |
| SMMT Summit Therapeutics Inc. | 76,648 | $785K | 0.16% | Added +5% |
| CTNM Contineum Therapeutics, Inc. | 86,654 | $769K | 0.15% | Added +43% |
| OKUR OnKure Therapeutics, Inc. | 240,963 | $660K | 0.13% | Unchanged |
| YARW Yarrow Bioscience, Inc. | 40,000 | $554K | 0.11% | New |
| COGT Cogent Biosciences, Inc. | 19,326 | $522K | 0.10% | Reduced −87% |
| IRLA IRulya Therapeutics Inc. | 11,989 | $495K | <0.1% | New |
| ERAS Erasca, Inc. | 34,976 | $491K | <0.1% | Reduced −89% |
| AMLX Amylyx Pharmaceuticals, Inc. | 18,558 | $480K | <0.1% | Added +28% |
| IKT Inhibikase Therapeutics, Inc. | 358,460 | $468K | <0.1% | Added +3% |
| AVLN Avalyn Pharma Inc. | 14,710 | $414K | <0.1% | New |
| LONA LeonaBio, Inc. | 158,253 | $369K | <0.1% | Added +3% |
| MBX MBX Biosciences, Inc. | 6,810 | $350K | <0.1% | Added +14% |
| CCCC C4 Therapeutics, Inc. | 140,000 | $348K | <0.1% | Reduced −63% |
| BEAM Beam Therapeutics Inc. | 15,844 | $339K | <0.1% | Added +80% |
| NGNE Neurogene Inc. | 14,700 | $333K | <0.1% | Reduced −33% |
| LSTA Lisata Therapeutics, Inc. | 371,411 | $330K | <0.1% | New |
| IRON Disc Medicine, Inc. | 4,100 | $307K | <0.1% | New |
| OBX Obsidian Therapeutics, Inc. | 23,077 | $277K | <0.1% | New |
| PALI Palisade Bio, Inc. | 272,204 | $251K | <0.1% | Unchanged |
| TECX Tectonic Therapeutic, Inc. | 12,000 | $251K | <0.1% | New |
| INO Inovio Pharmaceuticals, Inc. | 137,100 | $237K | <0.1% | New |
| GERN Geron Corporation | 258,900 | $235K | <0.1% | Reduced −76% |
| CATX Perspective Therapeutics, Inc. | 296,087 | $228K | <0.1% | Reduced −11% |
| IDYA IDEAYA Biosciences, Inc. | 7,950 | $206K | <0.1% | Reduced −79% |
| UNCY Unicycive Therapeutics, Inc. | 51,700 | $180K | <0.1% | Reduced −50% |
| ACRS Aclaris Therapeutics, Inc. | 44,200 | $154K | <0.1% | New |
| DRUG Bright Minds Biosciences Inc. | 6,395 | $136K | <0.1% | Unchanged |
| CMPX Compass Therapeutics, Inc. | 193,034 | $128K | <0.1% | Reduced −17% |
| ABEO Abeona Therapeutics Inc. | 48,745 | $120K | <0.1% | New |
| FTH Faeth Therapeutics, Inc. | 10,204 | $88K | <0.1% | New |
| LPCN Lipocine Inc. | 34,161 | $50K | <0.1% | Reduced −57% |
| IRD Opus Genetics, Inc. | 10,000 | $40K | <0.1% | Reduced −93% |
| PMN ProMIS Neurosciences, Inc. | 10,600 | $32K | <0.1% | Unchanged |
| PCSA Processa Pharmaceuticals, Inc. | 18,300 | $28K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| MIRM Mirum Pharmaceuticals, Inc. | 110,393 | $10.8M |
| MDGL Madrigal Pharmaceuticals, Inc. | 4,973 | $1.9M |
| AGIO Agios Pharmaceuticals, Inc. | 56,900 | $1.6M |
| SVRA Savara Inc. | 309,103 | $1.3M |
| XENE Xenon Pharmaceuticals Inc. | 33,300 | $1.2M |
| RLMD Relmada Therapeutics, Inc. | 348,265 | $1000K |
| CELC Celcuity Inc. | 16,252 | $890K |
| IHI iShares U.S. Medical Devices ETF | 13,800 | $774K |
| ENGN enGene Therapeutics Inc. | 411,065 | $721K |
| SNDX Syndax Pharmaceuticals, Inc. | 77,930 | $698K |
| LRMR Larimar Therapeutics, Inc. | 230,921 | $692K |
| TRVI Trevi Therapeutics, Inc. | 45,598 | $607K |
| KRYS Krystal Biotech, Inc. | 1,774 | $559K |
| EOLS Evolus, Inc. | 78,057 | $542K |
| GPCR Structure Therapeutics Inc. | 26,800 | $441K |
| BCRX BioCryst Pharmaceuticals, Inc. | 51,024 | $373K |
| VYGR Voyager Therapeutics, Inc. | 230,406 | $366K |
| OLMA Olema Oncology, Inc. | 31,476 | $224K |
| STOK Stoke Therapeutics, Inc. | 7,745 | $211K |
| VKTX Viking Therapeutics, Inc. | 7,404 | $188K |
| GLUE Monte Rosa Therapeutics, Inc. | 16,800 | $146K |
| MIST Milestone Pharmaceuticals Inc. | 270,233 | $102K |
| FULC Fulcrum Therapeutics, Inc. | 18,089 | $67K |
| WVE Wave Life Sciences, Inc. | 19,048 | $51K |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | 21,432 | $48K |
| CUE Cue Biopharma, Inc. | 10,702 | $45K |
| PMVP PMV Pharmaceuticals, Inc. | 53,569 | $38K |